Sunshine Biopharma (SBFM) Shares Outstanding (Diluted) (2021 - 2026)
Sunshine Biopharma (SBFM) recorded Shares Outstanding (Diluted) of 392,524 in Q2 2026, up 8.9% from 360,465 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Starting with Q4 2021, Sunshine Biopharma's Shares Outstanding (Diluted) history includes 19 quarters.
- Annual Shares Outstanding (Diluted) has a four-year compound annual growth rate of 134.1% (FY2021 to FY2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 70,175 in FY2024 (-42.3%), 121,660 in FY2023 (+60.3%), 75,904 in FY2022 (+481.2%) and 13,060 in FY2021.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased for four consecutive quarters, with growth averaging 113.2% over the last six quarters.
- Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 481.2% in Q4 2022, against a decline of 97.1% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 392,524 (Q1 2026), 392,524 (Q4 2025) and 392,524 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Sunshine Biopharma | 1.05 Mn | -38.04 Mn | 2.43 Mn | 392,524.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 392,524.00 |
| Mar 31, 2026 | 392,524.00 |
| Dec 31, 2025 | 392,524.00 |
| Sep 30, 2025 | 392,524.00 |
| Jun 30, 2025 | 360,465.00 |
| Mar 31, 2025 | 270,329.00 |
| Dec 31, 2024 | 70,175.00 |
| Sep 30, 2024 | 126,756.00 |
| Jun 30, 2024 | 4,973.00 |
| Mar 31, 2024 | 3,207.00 |
| Dec 31, 2023 | 121,660.00 |
| Sep 30, 2023 | 128,452.00 |
| Jun 30, 2023 | 126,751.00 |
| Mar 31, 2023 | 110,181.00 |
| Dec 31, 2022 | 75,904.00 |
| Sep 30, 2022 | 94,428.00 |
| Jun 30, 2022 | 79,248.00 |
| Mar 31, 2022 | 26,364.00 |
| Dec 31, 2021 | 13,060.00 |
API Access
Sunshine Biopharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();